文献
J-GLOBAL ID:201702256329841795
整理番号:17A1456004
CE TOFMSベースメタボロミクスアプローチによる尿毒症性溶質蓄積に及ぼす腸内細菌叢の影響の評価【Powered by NICT】
Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach
著者 (21件):
Mishima Eikan
(Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan)
,
Mishima Eikan
(Tohoku Medical Megabank Organization, Sendai, Japan)
,
Fukuda Shinji
(Institute for Advanced Biosciences, Keio University, Tsuruoka, Japan)
,
Fukuda Shinji
(Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency, Kawaguchi, Japan)
,
Mukawa Chikahisa
(Laboratory of Oncology, Pharmacy Practice and Sciences, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan)
,
Yuri Akinori
(Laboratory of Oncology, Pharmacy Practice and Sciences, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan)
,
Kanemitsu Yoshitomi
(Laboratory of Oncology, Pharmacy Practice and Sciences, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan)
,
Matsumoto Yotaro
(Laboratory of Oncology, Pharmacy Practice and Sciences, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan)
,
Akiyama Yasutoshi
(Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan)
,
Fukuda Noriko N.
(Institute for Advanced Biosciences, Keio University, Tsuruoka, Japan)
,
Tsukamoto Hiroki
(Laboratory of Oncology, Pharmacy Practice and Sciences, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan)
,
Asaji Kei
(Laboratory of Oncology, Pharmacy Practice and Sciences, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan)
,
Shima Hisato
(Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan)
,
Kikuchi Koichi
(Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan)
,
Suzuki Chitose
(Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan)
,
Suzuki Takehiro
(Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan)
,
Tomioka Yoshihisa
(Laboratory of Oncology, Pharmacy Practice and Sciences, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan)
,
Soga Tomoyoshi
(Institute for Advanced Biosciences, Keio University, Tsuruoka, Japan)
,
Ito Sadayoshi
(Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan)
,
Abe Takaaki
(Department of Medical Science, Tohoku University Graduate School of Biomedical Engineering, Sendai, Japan)
,
Abe Takaaki
(Department of Clinical Biology and Hormonal Regulation, Tohoku University Graduate School of Medicine, Sendai, Japan)
資料名:
Kidney International
(Kidney International)
巻:
92
号:
3
ページ:
634-645
発行年:
2017年
JST資料番号:
E0559B
ISSN:
0085-2538
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)